Document is current
Any future updates will be listed below
-
Authors
Kleef, R.
Nagy, R.
Baierl, A.
Bacher, V.
Bojar, H.
McKee, D. L.
Moss, R.
Thoennissen, N. H.
Szász, M.
Bakacs, T. https://orcid.org/0000-0002-9145-9276
-
Funding
Funding for this research was provided by:
ELKH Alfréd Rényi Institute of Mathematics
- License Information
-
More Information
Article History
Received: 8 March 2020
Accepted: 14 October 2020
First Online: 5 November 2020
Compliance with ethical standards
:
: RK holds international patent protection. TB is a partner and CSO of PRET Therapeutics Ltd, developing the patented low‐dose ICI combination therapy.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Treatment was performed on an individual basis (named patient use) with extensive written informed consent to undergo the treatment and retrospectively evaluate the data including patient’s consent to publish the data. Therefore, no formal ethical committee had to be involved.
